Menopausal status induces vaginal dysbiosis in women with human papillomavirus infection.
Human papillomavirus
Menopause
Microbiota
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 Mar 2024
26 Mar 2024
Historique:
received:
21
12
2023
accepted:
05
03
2024
medline:
26
3
2024
pubmed:
26
3
2024
entrez:
26
3
2024
Statut:
epublish
Résumé
In this study, we examined the difference in the vaginal microbiota of women infected with human papillomavirus (HPV), according to menopausal status. A total of 75 cervicovaginal swab samples from 38 pre- and 37 postmenopausal women with HPV infection were obtained from the Korean HPV cohort. Vaginal microbiota analysis, including microbial diversity and specific bacterial abundances, was performed using 16S rRNA gene sequencing. The mean age of the pre- and postmenopausal women were 29.5 and 55.8 years, respectively (p < 0.0001). Lactobacillus spp. were predominant in both groups; however, a marked decrease was observed in postmenopausal women compared to premenopausal women (44.3% vs. 74.2%). Various anaerobic bacteria also showed a relatively high abundance in the postmenopausal group; Atopobium vagina and Gardnerella vaginalis significantly increased in postmenopausal women. Interestingly, no significant differences in bacterial richness were observed between the two groups. However, significant differences in beta-diversity were observed using the Bray-Curtis (p = 0.001), Generalized UniFrac (p = 0.002), Jensen-Shannon (p = 0.001), and UniFrac algorithms (p = 0.002). Theres results indicate that postmenopausal women with HPV infection exhibited a higher degree of vaginal dysbiosis than premenopausal women. Further, HPV-infected postmenopausal women had increased vaginal microbial diversity, characterized by an increase in anaerobic bacteria and concomitant depletion of Lactobacillus spp.
Identifiants
pubmed: 38528061
doi: 10.1038/s41598-024-56314-9
pii: 10.1038/s41598-024-56314-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7092Subventions
Organisme : Korea Disease Control and Prevention Agency
ID : 2019-E5104-02
Informations de copyright
© 2024. The Author(s).
Références
Chesson, H. W., Dunne, E. F., Hariri, S. & Markowitz, L. E. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex. Transm. Dis. 41, 660–664 (2014).
doi: 10.1097/OLQ.0000000000000193
pubmed: 25299412
pmcid: 6745688
Okunade, K. S. Human papillomavirus and cervical cancer. J. Obstet. Gynaecol. 40, 602–608 (2020).
doi: 10.1080/01443615.2019.1634030
pubmed: 31500479
Chelimo, C., Wouldes, T. A., Cameron, L. D. & Elwood, J. M. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J. Infect. 66, 207–217 (2013).
doi: 10.1016/j.jinf.2012.10.024
pubmed: 23103285
International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8097 women with squamous cell carcinoma and 1374 women with adenocarcinoma from 12 epidemiological studies. Int. J. Cancer 120, 885–891 (2007).
doi: 10.1002/ijc.22357
Dugué, P. A., Rebolj, M., Garred, P. & Lynge, E. Immunosuppression and risk of cervical cancer. Expert. Rev. Anticancer Ther. 13, 29–42 (2013).
doi: 10.1586/era.12.159
pubmed: 23259425
Fasciana, T. et al. Socio-demographic characteristics and sexual behavioral factors of patients with sexually transmitted infections attending a hospital in Southern Italy. Int. J. Environ. Res. Public Health 18, 4722 (2021).
doi: 10.3390/ijerph18094722
pubmed: 33925258
pmcid: 8125464
Calagna, G. et al. ‘Secondary prevention’ against female HPV infection: Literature review of the role of carrageenan. Expert. Rev. Anti Infect. Ther. 18, 865–874 (2020).
doi: 10.1080/14787210.2020.1770082
pubmed: 32552158
Mitra, A. et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: What do we know and where are we going next? Microbiome 4, 58 (2016).
doi: 10.1186/s40168-016-0203-0
pubmed: 27802830
pmcid: 5088670
Lee, J. E. et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One 8, e63514 (2013).
doi: 10.1371/journal.pone.0063514
pubmed: 23717441
pmcid: 3661536
Gillet, E. et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: A meta-analysis. BMC Infect. Dis. 11, 10 (2011).
doi: 10.1186/1471-2334-11-10
pubmed: 21223574
pmcid: 3023697
Nilsen, T., Swedek, I., Lagenaur, L. A. & Parks, T. P. Novel selective inhibition of Lactobacillus iners by Lactobacillus-derived bacteriocins. Appl. Environ. Microbiol. 86, e01594–e1620 (2020).
doi: 10.1128/AEM.01594-20
pubmed: 32801180
pmcid: 7531956
So, K. A. et al. Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection. PLoS One 15, e0238705 (2020).
doi: 10.1371/journal.pone.0238705
pubmed: 32941440
pmcid: 7498004
Li, Y. et al. Vaginal microbiota and HPV infection: Novel mechanistic insights and therapeutic strategies. Infect. Drug Resist. 13, 1213–1220 (2020).
doi: 10.2147/IDR.S210615
pubmed: 32431522
pmcid: 7198448
Tuominen, H., Rautava, S., Syrjänen, S., Collado, M. C. & Rautava, J. HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa. Sci. Rep. 8, 9787 (2018).
doi: 10.1038/s41598-018-27980-3
pubmed: 29955075
pmcid: 6023934
Vitale, S. G. et al. The role of genital tract microbiome in fertility: A systematic review. Int. J. Mol. Sci. 23, 180 (2021).
doi: 10.3390/ijms23010180
pubmed: 35008605
pmcid: 8745627
Mueck, A. O., Ruan, X., Prasauskas, V., Grob, P. & Ortmann, O. Treatment of vaginal atrophy with estriol and lactobacilli combination: A clinical review. Climacteric 21, 140–147 (2018).
doi: 10.1080/13697137.2017.1421923
pubmed: 29381086
Stabile, G., Topouzova, G. A. & De Seta, F. The role of microbiota in the management of genitourinary syndrome of menopause. Climacteric 26, 353–360 (2023).
doi: 10.1080/13697137.2023.2223923
pubmed: 37366082
de Oliveira, N. S. et al. Postmenopausal vaginal microbiome and microbiota. Front. Reprod. Health 3, 780931 (2022).
doi: 10.3389/frph.2021.780931
pubmed: 36304005
pmcid: 9580746
Farage, M. & Maibach, H. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 27, 976–992 (2020).
doi: 10.1097/GME.0000000000001609
Burton, J. P. & Reid, G. Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. J. Infect. Dis. 186, 1770–1780 (2002).
doi: 10.1086/345761
pubmed: 12447763
Gustafsson, R. J. et al. The Lactobacillus flora in vagina and rectum of fertile and postmenopausal healthy Swedish women. BMC Womens Health 11, 17 (2011).
doi: 10.1186/1472-6874-11-17
pubmed: 21609500
pmcid: 3118184
Kim, S. et al. Changes in the microbiome of vaginal fluid after menopause in Korean Women. J. Microbiol. Biotechnol. 31, 1490–1500 (2021).
doi: 10.4014/jmb.2106.06022
pubmed: 34489372
pmcid: 9705842
Reimers, L. L. et al. The cervicovaginal microbiota and its associations with human papillomavirus detection in HIV-infected and HIV-uninfected women. J. Infect Dis. 214, 1361–1369 (2016).
doi: 10.1093/infdis/jiw374
pubmed: 27521363
pmcid: 5079369
Dareng, E. O. et al. Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. Epidemiol. Infect. 144, 123–137 (2016).
doi: 10.1017/S0950268815000965
pubmed: 26062721
Wu, S. et al. The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females. Gynecol. Oncol. 163, 348–357 (2021).
doi: 10.1016/j.ygyno.2021.08.016
pubmed: 34503848
Workowski, K. A. et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm. Rep. 70, 1–187 (2021).
doi: 10.15585/mmwr.rr7004a1
pubmed: 34292926
pmcid: 8344968
Smith, E. M. et al. Persistent HPV infection in postmenopausal age women. Int. J. Gynaecol. Obstet. 87, 131–137 (2004).
doi: 10.1016/j.ijgo.2004.07.013
pubmed: 15491557
So, K. A., Lee, I. H., Kim, T. J. & Lee, K. H. Risk factors of persistent HPV infection after treatment for high-grade squamous intraepithelial lesion. Arch. Gynecol. Obstet. 299, 223–227 (2019).
doi: 10.1007/s00404-018-4936-9
pubmed: 30341502
García-Piñeres, A. J. et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res. 66, 11070–11076 (2006).
doi: 10.1158/0008-5472.CAN-06-2034
pubmed: 17108147
Lee, W. C. et al. Establishment of a Korea HPV cohort study. J. Gynecol. Oncol. 24, 59–65 (2013).
doi: 10.3802/jgo.2013.24.1.59
pubmed: 23346315
pmcid: 3549509